Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Cathejell - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Cathejell

Approved

STANDARD

Cathejell

Pharmazeutische Fabrik Montavit GesmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 537b29d93282af70
Company: Pharmazeutische Fabrik Montavit GesmbH
Type: Standard

Approval Details

Approval Id: 537b29d93282af70
Drug Approval Philippines Name: Cathejell
Product Name: Cathejell
Registration Number: DR-XY45604
Brand Name: Cathejell
Generic Name: Lidocaine hydrochloride + Chlorhexidine dihydrochloride
Dosage Form: Gel for Instillation
Dosage Strength: 20 mg/500 mcg per gram (2% w/w / 0.05% w/w)
Manufacturer: Pharmazeutische Fabrik Montavit GesmbH
Importer: New Marketlink Pharmaceutical Corporation
Distributor: Metro Drug, Inc.
Issuance Date: 24 September 2021
Expiry Date: 04 October 2026
Pharmacologic Category: Anesthetic
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

537b29d93282af70

Type

Standard

Back to Philippines FDA Approvals